Thyroid-Roundtable.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Thyroid Nodules the American Thyroid Association®
® This page and its contents are Copyright © 2018 Thyroid Nodules the American Thyroid Association® FAQPage 1 of 2 WHAT IS THE THYROID GLAND? The thyroid gland located in the neck produces thyroid hormones which help the body use energy, stay warm and keep the brain, heart, muscles, and other organs working normally. 1 SYMPTOMS What are the symptoms of a thyroid nodule? The term thyroid nodule refers to any growth of thyroid cells that forms a lump within the thyroid. Most thyroid nodules do not cause any symptoms. Rarely, a nodule can cause pain, difficulty swallowing or breathing, hoarseness, or symptoms of hyperthyroidism. 2 CAUSES What causes a thyroid nodule? Fortunately, 9 out of 10 nodules are benign (noncancerous). These include colloid nodules, follicular neoplasms, and thyroid cysts. Autonomous nodules, which overproduce thyroid hormone, can occasionally lead to hyperthyroidism. We do not know what causes most noncancerous thyroid nodules to grow. Thyroid cancer is the most important cause of a thyroid nodule. Fortunately, cancer occurs in less than 10% of nodules (see Thyroid Cancer brochure). 3 DIAGNOSIS How is a thyroid nodule diagnosed? Most nodules are discovered during an examination of the neck for another reason. Blood tests of thyroid hormone (thyroxine, or T4) and thyroid-stimulating hormone (TSH) are usually normal. Specialized tests are necessary to determine whether a thyroid nodule is cancerous. You may be asked to undergo testing, such as a thyroid ultrasound, thyroid fine needle biopsy, or a thyroid scan. What is a Thyroid ultrasound? Thyroid ultrasound, which uses sound waves to obtain a picture of the thyroid should be used to evaluate thyroid nodules. -
The Thyroid Nodule Clinic INSIDE THIS ISSUE the Challenge Most Thyroid Nodules—About 95%—Are Entirely Points to Remember Benign
Current Trends in the Practice of Medicine Vol. 27, No. 1, 2011 The Thyroid Nodule Clinic INSIDE THIS ISSUE The Challenge Most thyroid nodules—about 95%—are entirely Points to Remember benign. However, identifying the occasional 2 Perspectives on thyroid cancer requires careful evaluation of every • Thyroid nodules are common, with the Continuing nodule found, using a combination of clinical palpable nodules found in 4% to 7% of Evolution of Therapy assessment, neck palpation, ultrasound imaging the adult US population and solitary or for Atrial Fibrillation (Figure 1), and, in many cases, analysis of a biopsy multiple nodules found at much higher specimen (Figure 2, see page 2). rates during ultrasonographic screening. Sometimes, thyroid nodules are noticed by 4 Advances in Seizure the patient or a family member or are discovered • Early diagnosis improves the likelihood Prevention and Prediction during a routine physical examination. They rarely that a cancer can be discovered while still cause symptoms, unless they are large enough contained within the thyroid gland and to interfere with swallowing. Thyroid cancer can amenable to surgery. 6 Childhood Fractures: invade and damage the recurrent laryngeal nerve, When to Worry causing hoarseness. Such invasion and damage are • Mayo Clinic endocrinologists opened the infrequent, however. Most nodules are incidental Thyroid Nodule Clinic in 2009, providing A discoveries, and now many more such nodules are coordinated care, a thorough assessment, discovered because of the increased use of imaging and a definitive diagnosis completed at a performed for other reasons, including carotid single visit. ultrasonography, neck or chest computed tomog- raphy, magnetic resonance imaging, and even positron emission tomography. -
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
THYROID Volume 16, Number 2, 2006 © American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Taskforce* Members: David S. Cooper,1 (Chair), Gerard M. Doherty,2 Bryan R. Haugen,3 Richard T. Kloos,4 Stephanie L. Lee,5 Susan J. Mandel,6 Ernest L. Mazzaferri,7 Bryan McIver,8 Steven I. Sherman,9 and R. Michael Tuttle10 Contents 1. Introduction . 4 2. Methods . 4 a. Literature search strategy b. Evaluation of the evidence 3. Thyroid Nodules . 5 a. Thyroid nodule evaluation iii. Laboratory studies iii. Fine needle aspiration biopsy iii. Multinodular goiter b. Thyroid nodule follow up and treatment ii. Long-term follow-up iii. Role of medical therapy iii. Thyroid nodules and pregnancy 4. Differentiated Thyroid Cancer . 8 a. Goals of therapy b. Role of preoperative staging with diagnostic testing c. Surgery for differentiated thyroid cancer iii. Extent of initial surgery iii. Completion thyroidectomy d. Pathological and clinical staging systems e. Postoperative radioiodine remnant ablation iii. Modes of thyroid hormone withdrawal iii. Role of diagnostic scanning before ablation iii. Radioiodine ablation dosage iv. Use of recombinant human thyrotropin for remnant ablation iv. Role of low iodine diets vi. Performance of post therapy scans f. Thyroxine suppression therapy g. Role of adjunctive external beam radiation or chemotherapy 5. Differentiated Thyroid Cancer: Long-Term Management . 13 a. Risk stratification for follow-up intensity b. Utility of serum thyroglobulin measurements c. Role of diagnostic radioiodine scans, ultrasound, and other imaging techniques d. Long-term thyroxine suppression therapy e. Management of patients with metastatic disease iii. -
Thyroid Nodules Update in Diagnosis and Management Shrikant Tamhane1* and Hossein Gharib2,3
Tamhane and Gharib Clinical Diabetes and Endocrinology (2015) 1:11 DOI 10.1186/s40842-015-0011-7 REVIEW ARTICLE Open Access Thyroid nodules update in diagnosis and management Shrikant Tamhane1* and Hossein Gharib2,3 Abstract Thyroid nodules are very common. With widespread use of sensitive imaging in clinical practice, incidental thyroid nodules are being discovered with increasing frequency. Their clinical importance is primarily related to the need to exclude malignancy (4.0 to 6.5 percent of all thyroid nodules), assess for their functional status and any pressure symptoms caused by them. New Molecular tests are marketed for the assessment of thyroid nodules for the presence of cancer. The high prevalence of thyroid nodules requires evidence-based rational strategies for their differential diagnosis, risk stratification, treatment, and follow-up. This review addresses advances and controversies in thyroid nodule evaluation, including the new molecular tests, and their management considering the current guidelines and supporting evidence. Keywords: Thyroid, Thyroid Nodules, Molecular markers, Benign, Malignant, FNA, Management, Ultrasonography Introduction disorders, benign and malignant can cause thyroid nod- Thyroid nodule is a discrete lesion within the thyroid ules (Table 1) [1, 5]. gland that is radiologically distinct from the surrounding Fine needle aspiration (FNA) biopsy is the most accur- thyroid parenchyma. Thyroid nodules are common. ate method for evaluating thyroid nodules and helps to They are discovered as an accidental finding by a pa- identify patients who require surgical resection [6]. If a tient, or as an incidental finding during a routine phys- serum TSH is normal or elevated, and the nodule meets ical examination in 3 to 7 % [1] or by a radiologic criteria for sampling, the next step in the evaluation of a procedure: 67 % with ultrasonography (US) imaging, thyroid nodule is a FNA biopsy. -
Hypothyroidism: Mimicker of Common Complaints Matthew C
Emerg Med Clin N Am 23 (2005) 649–667 Hypothyroidism: Mimicker of Common Complaints Matthew C. Tews, DOa, Sid M. Shah, MD, FACEPb,*, Ved V. Gossain, MD, FACP, FACEPc aCollege of Osteopathic Medicine, Emergency Medicine Residency Program, Michigan State University–Lansing, P.O. Box 30480, Lansing, MI 48909, USA bMichigan State University, Attending Physician Emergency Medicine, Ingham Regional Medical, Center 401 W. Greenlawn Avenue, Lansing, MI 48910, USA cDivision of Endocrinology, Department of Medicine, Michigan State University, Lansing, MI 48909, USA Patients with hypothyroidism may present with vague symptoms such as fatigue, arthralgias, myalgias, muscle cramps, headaches, and ‘‘not feeling well.’’ These are also among the more common complaints encountered by the emergency physicians. The disease spectrum of hypothyroidism ranges from an asymptomatic, subclinical condition to the rare, life-threatening myxedema coma, and thus can be a challenging diagnosis to make. A progressive and chronic disease, hypothyroidism results from diminished thyroid hormone production. It slows metabolic functions in every organ system in the body. Commonly, clinical presentation of hypothyroidism can be confused with effects of aging in the elderly, musculoskeletal or a psychiatric illness such as depression in the younger patients. Spontaneously occurring hypothyroidism is relatively common, with prevalence between 1% to 2%, and is 10 times more common in women than in men [1]. The probability of developing spontaneous hypothyroidism increases with age, with women having a mean age at diagnosis of around 60 years [2]. A recent survey showed that 9.5% out of nearly 26,000 visitors to a statewide health fair in Colorado had elevated circulating thyroid stimulating hormone (TSH) levels, indicating underlying hypothyroidism [3]. -
Thyroid Nodules MARY JO WELKER, M.D., and DIANE ORLOV, M.S., C.N.P
PRACTICAL THERAPEUTICS Thyroid Nodules MARY JO WELKER, M.D., and DIANE ORLOV, M.S., C.N.P. Ohio State University College of Medicine and Public Health, Columbus, Ohio Palpable thyroid nodules occur in 4 to 7 percent of the population, but nodules found incidentally on ultrasonography suggest a prevalence of 19 to 67 percent. The major- O A patient informa- ity of thyroid nodules are asymptomatic. Because about 5 percent of all palpable nod- tion handout on thy- roid nodules, written ules are found to be malignant, the main objective of evaluating thyroid nodules is to by the authors of this exclude malignancy. Laboratory evaluation, including a thyroid-stimulating hormone article, is provided on test, can help differentiate a thyrotoxic nodule from an euthyroid nodule. In euthyroid page 573. patients with a nodule, fine-needle aspiration should be performed, and radionuclide scanning should be reserved for patients with indeterminate cytology or thyrotoxico- sis. Insufficient specimens from fine-needle aspiration decrease when ultrasound guidance is used. Surgery is the primary treatment for malignant lesions, and the extent of surgery depends on the extent and type of disease. Ablation by postopera- tive radioactive iodine is done for high-risk patients—identified as those with metasta- tic or residual disease. While suppressive therapy with thyroxine is frequently used postoperatively for malignant lesions, its use for management of benign solitary thy- roid nodules remains controversial. (Am Fam Physician 2003;67:559-66,573-4. Copy- right© 2003 American Academy of Family Physicians.) Members of various thyroid nodule is a palpable jects 19 to 50 years of age had an incidental family practice depart- swelling in a thyroid gland with nodule on ultrasonography. -
A Practical Approach to the Diagnosis and Management of Thyroid Disorders Or
A Practical Approach to the Diagnosis and Management of Thyroid Disorders or All you wanted to know about thyroid disease but were afraid to ask Martin J. Abrahamson, MD Associate Professor of Medicine, Harvard Medical School Learning objectives • Understand the regulation of the hypothalamo-pituitary-thyroid axis • Develop an approach to screening and evaluation of patients with suspected thyroid dysfunction • Recognize causes of hyper and hypothyroidism and how to manage them • Develop an approach to the patient with thyroid nodular disease Regulation of thyroid hormone secretion Thyroid Function Tests • To diagnose thyroid dysfunction • The first step is to identify the patient who has an abnormality of thyroid function • To diagnose the cause of thyroid dysfunction • Then determine cause of the problem to determine best treatment What Does the TSH Level Mean? < 0.01-0.1 0.1-0.5 TRH hyperthyroid hyperthyroid (sub-clinical) TSH 0.5-5.0 > 5.0 T4/T3 euthyroid hypothyroid End Organ Suspected Primary Thyroid Dysfunction SENSITIVE TSH Undetectable Normal High Subnormal Suspect Euthyroid Suspect hypothyroid hyperthyroid Free T4 No further Free T4 Free T3** tests Elevated Normal Normal Low Subclinical Subclinical Hyperthyroid Hypothyroid hyperthyroidism hypothyroidism If measure Total T4 need **Free T3 indicated if FT4 normal measurement of TBG or T3 uptake TSH alone is not a diagnostic test • Unreliable in hypopituitarism - TSH levels inappropriately normal because of secretion of biolgically inactive hormone • May be unreliable post radioiodine treatment or during therapy with antithyroid drugs • Secondary hyperthyroidism may be missed • Unreliable in acutely ill patients or those on dopamine or steroids Screening For Thyroid Disease: Who Should be Screened?* 1. -
Endocrine Module (PYPP 5260), Thyroid Section, Spring 2002
Endocrine Module (PYPP 5260), Thyroid Section, Spring 2002 THYROID HORMONE TUTORIAL: THYROID PATHOLOGY Jack DeRuiter I. INTRODUCTION Thyroid disorder is a general term representing several different diseases involving thyroid hormones and the thyroid gland. Thyroid disorders are commonly separated into two major categories, hyperthyroidism and hypothyroidism, depending on whether serum thyroid hormone levels (T4 and T3) are increased or decreased, respectively. Thyroid disease generally may be sub-classified based on etiologic factors, physiologic abnormalities, etc., as described in each section below. More than 13 million Americans are affected by thyroid disease, and more than half of these remain undiagnosed. The American Association of Clinical Endocrinologists (AACE) has initiated a campaign to increase public awareness of thyroid disorders and educate Americans about key periods, from birth to advanced age, when people are at increased risk for developing a thyroid disorder (see below). The diagnosis of thyroid disease can be particularly challenging. Patients often present with vague, general clinical manifestations; in particular, the elderly may not associate the signs and symptoms with a disease process and thus may not bring them to the attention of their primary care provider. The prevalence and incidence of thyroid disorders is influenced primarily by sex and age. Thyroid disorders are more common in women than men, and in older adults compared with younger age groups. The prevalence of unsuspected overt hyperthyroidism and hypothyroidism are both estimated to be 0.6% or less in women, based on several epidemiologic studies. Age is also a factor; for overt hyperthyroidism, the prevalence rate is 1.4% for women aged 60 or older and 0.45% for women aged 40 to 60. -
Thyroid Hormone Resistance in Two Patients with Papillary
case report Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status 1 Diskapi Yildirim Beyazit Training and Research Hospital, Melia Karakose1, Mustafa Caliskan1, Muyesser Sayki Arslan1, Department of Endocrinology 1 2 1,3 and Metabolism, Ankara, Turkey Erman Cakal , Ahmet Yesilyurt , Tuncay Delibasi 2 Diskapi Yildirim Beyazit Training and Research Hospital, Department of Stem Cell and Genetic Diagnostic Center, Ankara, Turkey SUMMARY 3 Hacettepe University, School of Medicine (Kastamonu), Department Resistance to thyroid hormone (RTH) is a rare autosomal dominant hereditary disorder. Here in, we of Internal Medicine, Ankara, Turkey report two patients with RTH in whom differentiated thyroid cancer was diagnosed. Two patients were admitted to our clinic and their laboratory results were elevated thyroid hormone levels with Correspondence to: Melia Karakose unsuppressed TSH. We considered this situation thyroid hormone resistance in the light of laboratory Diskapi Hospital, and clinical datas. Thyroid nodule was palpated on physical examination. Thyroid ultrasonography Irfan- Bastug Caddesi, showed multiple nodules in both lobes. Total thyroidectomy was performed. The pathological fin- Ankara, Turkey [email protected] dings were consistent with papillary thyroid microcarcinoma. BRAFV600E mutation analysis results were negative. RTH is very rare and might be overlooked. There is no consensus on how to overcome Received on May/16/2014 the persistently high TSH in patients with RTH and differentiated thyroid cancer (DTC). Further studies Accepted on Nov/24/2014 are needed to explain the relationship between RTH and DTC which might be helpful for the treat- DOI: 10.1590/2359-3997000000091 ment of these patients. Arch Endocrinol Metab. -
Thyroid Emergencies
REVIEW ARTICLE Thyroid emergencies Dorina Ylli1, Joanna Klubo ‑Gwiezdzinska2, Leonard Wartofsky3,4 1 Endocrinology Division, University of Medicine, Tirana, Albania 2 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States 3 Endocrinology Division, Department of Medicine, Georgetown University School of Medicine, Washington DC, United States 4 MedStar Health Research Institute, MedStar Washington Hospital Center, Washington DC, United states KEY WORDS ABSTRACT coma, critical care, Myxedema coma and thyroid storm are among the most common endocrine emergencies presenting to hypothermia, general hospitals. Myxedema coma represents the most extreme, life ‑threatening expression of severe hypothyroidism, hypothyroidism, with patients showing deteriorating mental status, hypothermia, and multiple organ thyrotoxicosis system abnormalities. It typically appears in patients with preexisting hypothyroidism via a common pathway of respiratory decompensation with carbon dioxide narcosis leading to coma. Without early and appropriate therapy, the outcome is often fatal. The diagnosis is based on history and physical find‑ ings at presentation and not on any objective thyroid laboratory test. Clinically based scoring systems have been proposed to aid in the diagnosis. While it is a relatively rare syndrome, the typical patient is an elderly woman (thyroid hypofunction being much more common in women) who may or may not have a history of previously diagnosed or treated thyroid dysfunction. Thyrotoxic storm or thyroid crisis is also a rare condition, established on the basis of a clinical diagnosis. The diagnosis is based on the pres‑ ence of severe hyperthyroidism accompanied by elements of systemic decompensation. Considering that mortality is high without aggressive treatment, therapy must be initiated as early as possible in a critical care setting. -
Thyroid Disease and Testing
THYROID DISEASE AND TESTING Jack L. Snitzer, D.O., FACOI, FACE, CCD MAPA MEETING 2018 JACK L. SNITZER, D.O. 410-572-8848 [email protected] NO CONFLICTS OF INTEREST THYROID THYROID • Goiter • Hyperthyroidism (overt and “subclinical”) • Hypothyroidism (overt and “subclinical”) • Nodules • Cancer • Blood Tests • Radiologic tests • Medications Frequency of thyroid issues • Autoimmune thyroid disease (Hashimoto’s and Graves’) is about 7 times more common in women than men • 1 out of every 10-20 women will develop hypo- or hyperthyroidism • Goiter: up to one of every 10-20 people • Nodule(s): up to one of every 10-20 people PALPATION • Low anterior neck • I prefer palpating from in front of the patient, so I can see simultaneously see what and where I am palpating. I use one hand and then the other hand. • Many people palpate from behind. PALPATATION • From the from, use thumbs and/or fingers. Might need to use each hand (I often feel with my right fingers and thumb [standing on the patient’s right] and confirm using my left fingers and thumb [standing on the patient’s left side]) PALPATION • Neck in neutral position usually, so the neck muscles don’t tense up (you might end up feeling the muscles more than the thyroid) • So, don‘t over-extend the neck. • Don’t have the next flexed with the chin down (the thyroid might then drop too low, below the sternum) PALPATION • Large neck muscles might confuse the patient and practitioner and might make the neck look larger. Might have to move the neck muscles out of the way with your fingers (palpate medial to the neck muscles [sternocleidomastoid]) PALPATION • A fat pad over the sternal notch/upper sternum often looks like a goiter, but is soft and anterior to the thyroid on palpation. -
Toxic Multinodular Goitre: a Surprising Finding Marlene Rodrigues,1 Helena Ferreira,2 Ana Antunes,1,3 Olinda Marques3,4
Images in… BMJ Case Reports: first published as 10.1136/bcr-2017-221913 on 12 September 2017. Downloaded from Toxic multinodular goitre: a surprising finding Marlene Rodrigues,1 Helena Ferreira,2 Ana Antunes,1,3 Olinda Marques3,4 1Department of Pediatrics, DESCRIPTION Hospital de Braga, Braga, A 16-year-old healthy adolescent boy was referred Portugal 2 to the paediatric endocrinology clinic because of Department of Pediatrics, multiple thyroid nodules detected by cervical Hospital da Senhora da Oliveira ultrasound, in the context of cervical lymphade- Guimaraes EPE, Guimaraes, Portugal nopathies. There was no family history of thyroid Figure 1 Cervical ultrasound revelling multiples 3Pediatric Endocrinology Unit, disease. He denied recent infections, asthenia, nodules in the right thyroid lobe. (A) Predominantly Hospital de Braga, Braga, weight loss, sweating, palpitations, mood or sleep cystic nodule, (B) characteristic mixed nodule and (C) Portugal disturbances, dysphagia or dysphonia. At physical predominantly solid nodule. 4Department of Endocrinology, examination, an enlarged, irregular and fibro- Hospital de Braga, Braga, elastic thyroid, with a predominant right lobe, Portugal was identified. The remaining examination was Thyroid nodules are a frequent incidental normal. finding with an incidence between 9.4% and Correspondence to The analytical profile was thyroid stimulating 27.0%.1 In contrast to adults, TMNG is an Dr Marlene Rodrigues, rodrigues. f. marlene@ gmail. com hormone (TSH) <0.01 uUI/mL (normal 0.5–4.8 uncommon thyroid disease in paediatric age. The uUI/mL), free triiodothyronine (FT3) 7.27 pg/mL presence of hyperthyroidism determines the need Accepted 3 September 2017 (normal 2.3–4.2 pg/mL) and free thyroxine (FT4) for a definitive therapy in multinodular goitre, and 2.02 ng/dL (normal 0.8–2.3 ng/dL).